EU Court Backs Astra Antitrust Fine Over Patent Abuse
A European court affirmed on Thursday a 2005 European Commission decision that AstraZeneca PLC abused its market dominance and the patent system in order to block generic competitors for its blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article